No Data
No Data
Innovative Phar (00399): Kaiyuan Xinde resigns as the auditor.
Innovative phar (00399) announced that the board of directors and the company's audit committee have received the report from Kaiyuan Xinde Certified Public Accountants...
Innovative Pharmaceutical Biotech's (HKG:399) Earnings Might Not Be As Promising As They Seem
Extrawell Pharmaceutical Extends Loan Agreement, Grants New Loan Facility
Innovative Pharmaceutical Biotech Swings to Profit in Fiscal 2024
INNOVATIVE PHAR: Annual Report 2024
Innovative Phar announced its annual performance, with a net profit attributable to shareholders of HK$103 million, turning losses into gains year-on-year.
In the fiscal year ending March 31, 2024, innovative phar (00399) announced its annual results, with a revenue of HKD 6.59 million, a decrease of 18.35% year-on-year; the net profit attributable to shareholders was HKD 103 million, compared to a loss of HKD 2.46 billion in the same period last year; basic earnings per share was HKD 0.0677. The announcement stated that the main reason for the turnaround was due to the revenue from the revised convertible bonds of HKD 330 million obtained in this fiscal year.
No Data